You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

CNX embarks on buy-and-build strategy

CNX Therapeutics, a company focusing on improving access to medicines, has announced that it has successfully completed the acquisition of Synchrony Pharma Limited and its existing portfolio of commercialised products.